John K Mcpherson

US Patent:

20020161748, Oct 31, 2002

Filed:

Jul 24, 2001

Appl. No.:

09/912586

Inventors:

Elizabeth Hamel - Morgan Hill, CA
Michael Ho - Willowdale, CA
James Kleewein - San Jose CA, US
Mark Lcilch - Ajax, CA
Sam Lightstone - Toronto, CA
John McPherson - San Jose CA, US
James Ruddy - Gilroy CA, US

Assignee:

International Business Machines Corporation

International Classification:

G06F007/00

US Classification:

707/003000

Abstract:

A method, apparatus and article of manufacture is provided for loading data from a remote data source record by record, in a computer system network connecting a source site and a target site via a database connection communication line. The source site has at least one data source and a Distributed Relational Database Architecture (DRDA) software server having multi-database access to DBMSs. The target site requests data loading from the source site DRDA via a block of Structured Query Language (SQL) statements. Data are transported record by record via the database connection communication line according to the DRDA communication protocol, wherein the target site loads records concurrently with the unloading of records in the source site. The data loading may also be performed in a pipeline manner, loading data records in multiple partitions with a plurality of parallel streams, pointed to by a plurality of data source partition cursors.

US Patent:

20050165718, Jul 28, 2005

Filed:

Jan 26, 2004

Appl. No.:

10/764772

Inventors:

Marcus Fontoura - San Jose CA, US
Reiner Kraft - Gilroy CA, US
Tony Leung - San Jose CA, US
John McPherson - San Jose CA, US
Andreas Neumann - Gilroy CA, US
Runping Qi - Cupertino CA, US
Sridhar Rajagopalan - Oakland CA, US
Eugene Shekita - San Jose CA, US
Jason Zien - San Jose CA, US

International Classification:

G06F007/00

US Classification:

707001000

Abstract:

Disclosed is a technique for building an index in which global analysis computations and index creation are pipelined, wherein the global analysis computations share intermediate results.

US Patent:

20070282829, Dec 6, 2007

Filed:

Aug 17, 2007

Appl. No.:

11/840881

Inventors:

Marcus Fontoura - San Jose CA, US
Reiner Kraft - Gilroy CA, US
Tony Leung - San Jose CA, US
John McPherson - San Jose CA, US
Andreas Neumann - Gilroy CA, US
Runping Qi - Cupertino CA, US
Sridhar Rajagopalan - Oakland CA, US
Eugene Shekita - San Jose CA, US
Jason Zien - San Jose CA, US

Assignee:

INTERNATIONAL BUSINESS MACHINES CORPORATION - Armonk NY

International Classification:

G06F 17/30

US Classification:

707005000

Abstract:

Disclosed is a technique for building an index. A new indexis built and an anchor text tableand a duplicates tabletare output using a stores, a delta store, and previously generated global analysis computations, wherein the previously generated global analysis computationsinclude an anchor text table, a rank table, and a duplicates table. New global analysis computationsare generated using the anchor text table, the duplicates table, and the previously generated global analysis computations.

US Patent:

48164429, Mar 28, 1989

Filed:

Nov 7, 1986

Appl. No.:

6/928760

Inventors:

John M. McPherson - Sunnyvale CA
Danile R. Twardzik - Bainbridge Island WA
George J. Todaro - Seattle WA
Karl A. Piez - Menlo Park CA
Jane E. Ranchalis - Seattle WA

Assignee:

Collagen Corporation - Palo Alto CA

International Classification:

A61K 3700

US Classification:

514 12

Abstract:

Polypeptides called cartilage-inducing factors (CIFs) that are found in bone and have heretofore been identified as having in vitro cartilage-inducing activity. TGF-. beta. activity, and anti-inflammatory activity have now been found to possess potent oncostatic activity. The CIFs showed oncostatic activity on human and animal tumors, including carcinomas, adenocarcinomas, lymphomas, and melanomas.

US Patent:

55465706, Aug 13, 1996

Filed:

Feb 17, 1995

Appl. No.:

8/390112

Inventors:

John A. McPherson - San Jose CA
Mir H. Pirahesh - San Jose CA
Tuong C. Truong - San Jose CA
Daniel J. Coyle - Sunnyvale CA

Assignee:

International Business Machines Corporation - Armonk NY

International Classification:

G06F 1730

US Classification:

395600

Abstract:

The present invention provides an evaluation strategy for the execution of SQL queries involving recursion and table queues in a relational database management system. The table queue is established for the query in the memory of the computer, and tuples are generated by tuple-producing operators in the query for storage into the table queue. As operators of the query read the stored tuples from the table queue, a first end-of-file condition, termed a Temporary End-Of-File, occurs when all of the tuples currently stored in the table queue have been retrieved and control is returned to the operator reading from the table queue. A retry request for additional tuples is generated by the operator through the table queue to the tuple-producing operators. If the tuple-producing operators can generate additional tuples, then these additional tuples are stored into the table queue and control is returned to the operator reading from the table queue in response to the retry request. If the tuple-producing operators cannot generate the additional tuples, then a second end-of-file condition, termed a Permanent End-Of-File, occurs and control is returned to the operator reading from the table queue.

US Patent:

50248413, Jun 18, 1991

Filed:

Jun 30, 1988

Appl. No.:

7/213726

Inventors:

George H. Chu - Sunnyvale CA
Yasushi Ogawa - Pacifica CA
John M. McPherson - Hopkinton MA
George Ksander - Redwood City CA
Bruce Pratt - Union City CA
Diana Hendricks - Brea CA
Hugh McMullin - San Bruno CA

Assignee:

Collagen Corporation - Palo Alto CA

International Classification:

A61F 1300
A61K 914
A61K 3712
A61K 31725

US Classification:

424422

Abstract:

Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0. 01 to 0. 3 g/cm. sup. 3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250 microns. The implants are capable of promoting connective tissue deposition, angiogenesis, reepithelialization, and fibroplasia. The wound healing matrix also serves as an effective sustained delivery system for bioactive agents.

US Patent:

52195767, Jun 15, 1993

Filed:

Dec 3, 1991

Appl. No.:

7/801732

Inventors:

George H. Chu - Sunnyvale CA
Yasushi Ogawa - Pacifica CA
John M. McPherson - Hopkinton MA
George Ksander - Redwood City CA
Bruce Pratt - Union City CA
Diana Hendricks - Brea CA
Hugh McMullin - San Bruno CA

Assignee:

Collagen Corporation - Palo Alto CA

International Classification:

A61K 914

US Classification:

424484

Abstract:

Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0. 01 to 0. 3 g/cm. sup. 3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250 microns. The implants are capable of promoting connective tissue deposition, angiogenesis, reepithelialization, and fibroplasia. The wound healing matrix also serves as an effective sustained delivery system for bioactive agents.

US Patent:

51106043, May 5, 1992

Filed:

Dec 19, 1990

Appl. No.:

7/630299

Inventors:

George H. Chu - Sunnyvale CA
Yasushi Ogawa - Pacifica CA
John M. McPherson - Framingham MA
George Ksander - Redwood City CA
Bruce Pratt - Union City CA
Diana Hendricks - Brea CA
Hugh McMullin - San Bruno CA

Assignee:

Collagen Corporation - Palo Alto CA

International Classification:

A61K 914
A61K 3766
A61K 3712
A61K 3724

US Classification:

424484

Abstract:

Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0. 01 to 0. 3 g/cm. sup. 3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250 microns. The implants are capable of promoting connective tissue deposition, angiogenesis, reepithelialization, and fibroplasia. The wound healing matrix also serves as an effective sustained delivery system for bioactive agents.